Vimarsana
Biggest News Aggregation in the World

Cdr Rule News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cdr Rule. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cdr Rule Today - Breaking & Trending Today

Texas Federal District Court Vacates IDR Rule of No Surprises Act - Vimarsana News

Texas Federal District Court Vacates IDR Rule of No Surprises Act

The United States District Court for the Eastern District of Texas ruled in favor of the Texas Medical Association and vacated portions of the final rule adopted in August 2022 that applied to the Independent Dispute Resolution process created by the No Surprises Act.

340B Cases Between January 24 to 30, 2023 - Vimarsana News

340B Cases Between January 24 to 30, 2023

An opinion was issued in one of the three federal Appeals Court cases addressing contract pharmacy restrictions. The Court found that HHS could not require drug manufacturers to provide 340B pricing on drugs shipped to an unlimited number of contract pharmacies.

340B Lawsuits January 9 to 16, 2023 - Vimarsana News

340B Lawsuits January 9 to 16, 2023

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. A District Court issued an opinion in AHA v. Becerra remanding the issue of remedies. 7 cases will remain stayed pending a decision in AHA v. Becerra

EPA Revising TSCA Chemical Data Reporting Rule - Vimarsana News

EPA Revising TSCA Chemical Data Reporting Rule

Tuesday, December 29, 2020 A federal court has ordered EPA to make extensive changes to its Chemical Data Reporting rule (CDR) with respect to asbestos reporting. While the ruling in  ADAO v. Wheeler is limited to CDR reporting of asbestos, it sets the stage for targeted reporting requirements by manufacturers and possibly processors for other substances being considered for prioritization or that are the subjects of risk evaluations. Such requirements might include elimination of the exemptions for substances in articles or present only as impurities and reporting by processors. ...